Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
An experimental drug duo may cure some cases of the liver disease hepatitis C, without the severe side effects of standard therapy, a new clinical trial suggests. The study, of 362 people with chronic hepatitis C, found that the new drugs—combined with one older drug—cleared the virus from up to 69 percent of patients. And that was without having to use interferon, a difficult-to-take injection drug that is part of the current therapy.
Hey, check out all the research scientist jobs. Post your resume today!
